The vitellogenin-binding protein (VBP) is a member of the proline and acidic-region rich (PAR) family of bZip transcription factors. PAR is located N-terminally to the DNA-binding domain. VBP binds to specific sites within the 300-bp 5′-flanking region of the chicken-liver-specific estrogen-dependent very-low-density apolipoprotein gene (apoVLDL II). One of these binding sites (site D) resembles the albumin site D and is positioned in close proximity of the major estrogen-responsive element. Previous studies showed that VBP can bind simultaneously with the estrogen receptor to the putative complex regulatory element E1D. To investigate whether VBP is involved in apoVLDL II gene expression, we examined its capacity to enhance apoVLDL II transcription and its presence in liver. We show that VBP is capable of enhancing transcription in transfection experiments. However, VBP could not be detected in liver by Western-blots or immuno-electro mobility shift assays (EMSAs) using antibodies against different moieties of the protein. We examined the possible reduction in translation efficienies due to a small upstream open reading frame in the VBP leader sequence, but did not find any. Although VBP binds to the proximal apoVLDL II promoter region and enhances transcription in co-transfection experiments, the protein is unlikely to be involved in apoVLDL II gene transcription because of its undetectable low level in liver nuclei. . The VBP gene consist of six exons, which can form four different mRNAs by alternative usage of exons 1 and 2 for the N-terminus and exons 5 and 6 for the C-terminus [2]. The corresponding protein isoforms are called AA, βA, Aβ and ββ, depending whether they are encoded by exon 1-3-4-5, 1-3-4-6, 2-3-4-5 or 2-3-4-6, respectively. In addition to these four isoforms, a longer mRNA, resulting from an alternative polyadenylation site located in exon 5, was identified [2]. The described AA form represents the liver transcript [1,3].The albumin-site-D-binding protein (DBP) [7], the hepatic leukaemia factor (HLF) [8,9], the thyrotroph embryonic factor (TEF) [10] and Drosophila par domain protein 1 (PDP1) [11] Correspondence to M. P. Smidt, Department of Medical Pharmacology, Rudolf Magnus Institute for Neurosciences, Universiteitsweg 100, NL-3584 CG Utrecht, The Netherlands Fax: ϩ31 30 2539032. E-mail: Smidt@med.ruu.nl Abbreviations. VBP, vitellogenine binding protein ; ApoVLDL II, very-low-density apolipoprotein II; PAR, proline and acidic-region rich; ERE, estrogen-responsive element; EMSA, electromobility assay ; uORF, upstream open reading frame; DBP, albumin-site-D-binding protein; HLF, hepatic nuclear factor; TEF, thyrotroph embryonic factor; PDP1, par domain protein 1; C/CEBP, CCAAT-enhancer-binding protein; TK-CAT, timidine kinase-chloramphenicol acetyl tranferase; LMH, leghorn strain M ; HRP, horse radish peroxidase ; ssDBF, single-stand-DNA-binding factor; CPA1, carbamoyl-phosphate synthase A; CMV, cytomegalovirus.are other members of the PAR subfamily. TEF was cloned from rat brain and, on the...